(Q27261089)

English

semaglutide

medication used to treat type 2 diabetes and obesity

  • Semaglutide

Statements

Semaglutide.svg
2,014 × 1,285; 260 KB
0 references
Semaglutid 3Letter.svg
864 × 225; 66 KB
0 references
Semaglutide PDB=7ki0.png
1,000 × 743; 264 KB
0 references
4,113.122 dalton
1 reference
C₁₈₇H₂₉₁N₄₅O₅₉
1 reference
1 reference
FDA-sourced list of all drugs with black box warnings (Use Download Full Results and View Query links. (English)
Semaglutide
0 references

Identifiers

1 reference
18-[[(1R)-4-[2-[2-[2-[2-[2-[2-[[(5S)-5-[[(2S)-2-[[(2S)-2-[[(2S)-5-amino-2-[[2-[[(2S)-2-[[(2S)-2-[[(2S)-2-[[(2S)-2-[[(2S)-2-[[(2S)-2-[[(2S)-2-[[(2S)-2-[[(2S,3R)-2-[[(2S)-2-[[(2S,3R)-2-[[2-[[(2S)-2-[[2- (English)
19 November 2016
691-729-9
1 reference
27 December 2018
N6.26-{18-[N-(17-carboxyheptadecanoyl)-L-γ-glutamyl]-10-oxo-3,6,12,15-tetraoxa-9,18- diazaoctadecanoyl}-[8-(2-amino-2-propanoic acid),34-L-arginine]human glucagon-like peptide 1(7-37) (English)
CAS no.: 910463-68-2 (English)
1 reference
27 December 2018
N6.26-{18-[N-(17-carboxyheptadecanoyl)-L-γ-glutamyl]-10-oxo-3,6,12,15-tetraoxa-9,18- diazaoctadecanoyl}-[8-(2-amino-2-propanoic acid),34-L-arginine]human glucagon-like peptide 1(7-37) (English)
CAS no.: 910463-68-2 (English)
0 references
0 references
0 references
 
edit
    edit
      edit
        edit
          edit
            edit
              edit
                edit